Trial intelligence / Profile preview

Atorvastatin for treatment of ulcerative colitis

IRCT2016102730528N1Phase 2Completed

Sponsor
Zahedan University of Medical Sciences
Start
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of atorvastatin in autoimmune colitis, sponsored by Zahedan University of Medical Sciences. Started Jul 2015; status: completed.

02

Drugs

atorvastatin
03

Conditions

autoimmune colitis

Beyond the preview

Go deeper on IRCT2016102730528N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016102730528N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call